A cardiologist reflects on 25 years of statewide collaboration through the Blue Cross Blue Shield of Michigan Cardiovascular Consortium.

Researchers developed an HDL-mimicking nanoparticle that modified heart disease-related plaques in preclinical research.

A new publication shows how more varied samples push science even further than homogeneous studies of the past.

Nicole Bhave, M.D. joins us to sort out answers to the most searched questions about the “silent killer” that is high blood pressure.

Medical students can benefit from mentorship in a number of ways, including guidance that helps facilitate student-led scientific research.

A human genetics experts discusses how these DNA tests might be useful in practice and what cautions remain.

Adding tricuspid repair to the OR docket makes sense for some patients already undergoing surgery for degenerative mitral regurgitation, a new study shows.

Preclinical research allows for a more efficient analysis of heart conditions.

A pre-clinical study explores the role of hormones in the COVID-19 vascular damage that’s generally worse in men than in women.

A third of children and adolescents who underwent a complex procedure for a severe congenital heart condition were identified as frail.

Participants from the University of Michigan Health-led research range in age, race and health conditions.

Genetic meta-analysis helps researchers detect genes related to this cardiovascular disease that affects mostly women and defines relationships to other more common cardiovascular conditions.

The novel procedure allows patients to have their valve replaced with a larger prosthetic, which significantly improves blood flow.

Home blood pressure monitoring is important for people with hypertension or a history of stroke, heart failure, diabetes and heart attack, but a new poll shows many people don’t do it.

For adults over 65 who need more blood pressure control, increasing the dose of an existing medication may be a better choice for many than adding a new drug.